United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
529.39
+8.17 (1.57%)
Mar 24, 2026, 12:16 PM EDT - Market open
United Therapeutics Employees
United Therapeutics had 1,400 employees as of December 31, 2025. The number of employees increased by 95 or 7.28% compared to the previous year.
Employees
1,400
Change (1Y)
95
Growth (1Y)
7.28%
Revenue / Employee
$2,273,357
Profits / Employee
$953,357
Market Cap
23.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,400 | 95 | 7.28% |
| Dec 31, 2024 | 1,305 | 137 | 11.73% |
| Dec 31, 2023 | 1,168 | 183 | 18.58% |
| Dec 31, 2022 | 985 | 20 | 2.07% |
| Dec 31, 2021 | 965 | 15 | 1.58% |
| Dec 31, 2020 | 950 | 30 | 3.26% |
| Dec 31, 2019 | 920 | 60 | 6.98% |
| Dec 31, 2018 | 860 | 60 | 7.50% |
| Dec 31, 2017 | 800 | 50 | 6.67% |
| Dec 31, 2016 | 750 | 0 | - |
| Dec 31, 2015 | 750 | 10 | 1.35% |
| Dec 31, 2014 | 740 | 34 | 4.82% |
| Dec 31, 2013 | 706 | 83 | 13.32% |
| Dec 31, 2012 | 623 | 80 | 14.73% |
| Dec 31, 2011 | 543 | 23 | 4.42% |
| Dec 31, 2010 | 520 | 110 | 26.83% |
| Dec 31, 2009 | 410 | 50 | 13.89% |
| Dec 31, 2008 | 360 | 40 | 12.50% |
| Dec 31, 2007 | 320 | 35 | 12.28% |
| Dec 31, 2006 | 285 | 75 | 35.71% |
| Dec 31, 2005 | 210 | 40 | 23.53% |
| Dec 31, 2004 | 170 | 10 | 6.25% |
| Dec 31, 2003 | 160 | 10 | 6.67% |
| Dec 31, 2002 | 150 | 22 | 17.19% |
| Dec 31, 2001 | 128 | 18 | 16.36% |
| Dec 31, 2000 | 110 | 47 | 74.60% |
| Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,561 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
UTHR News
- 12 days ago - United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine - Business Wire
- 13 days ago - United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) - Seeking Alpha
- 14 days ago - United Therapeutics Corporation (UTHR) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 15 days ago - United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program - Business Wire
- 21 days ago - United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference - Business Wire
- 21 days ago - United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 21 days ago - United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension Transcript - Seeking Alpha
- 22 days ago - United Therapeutics' blood pressure drug meets main, secondary goals in late-stage study - Reuters